QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
Log in
NASDAQ:BLFS

BioLife Solutions Stock Forecast, Price & News

$42.73
+2.13 (+5.25 %)
(As of 01/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$39.46
Now: $42.73
$44.31
50-Day Range
$36.54
MA: $41.20
$45.75
52-Week Range
$7.37
Now: $42.73
$47.22
Volume372,772 shs
Average Volume313,529 shs
Market Capitalization$1.40 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.55
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools for the cell and gene therapy industry in North America, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; and liquid nitrogen laboratory freezers, cryogenic equipment, and accessories. The company markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was founded in 1987 and is headquartered in Bothell, Washington.
BioLife Solutions logo

MarketRank

Overall MarketRank

1.70 out of 5 stars

Medical Sector

106th out of 1,926 stocks

Electromedical Equipment Industry

4th out of 61 stocks

Analyst Opinion: 1.4Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:BLFS
CUSIPN/A
Phone425-402-1400
Employees54

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$27.37 million
Cash Flow$0.21 per share
Book Value$2.12 per share

Profitability

Net Income$-1,660,000.00

Miscellaneous

Market Cap$1.40 billion
Next Earnings Date3/10/2021 (Estimated)
OptionableNot Optionable
$42.73
+2.13 (+5.25 %)
(As of 01/21/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BLFS News and Ratings via Email

Sign-up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











BioLife Solutions (NASDAQ:BLFS) Frequently Asked Questions

How has BioLife Solutions' stock been impacted by COVID-19?

BioLife Solutions' stock was trading at $12.25 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BLFS shares have increased by 248.8% and is now trading at $42.73.
View which stocks have been most impacted by COVID-19
.

Is BioLife Solutions a buy right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for BioLife Solutions in the last twelve months. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" BioLife Solutions stock.
View analyst ratings for BioLife Solutions
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than BioLife Solutions?

Wall Street analysts have given BioLife Solutions a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but BioLife Solutions wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Doug Parker's approval rating as BioLife Solutions' CEO?

1,448 employees have rated BioLife Solutions CEO Doug Parker on Glassdoor.com. Doug Parker has an approval rating of 60% among BioLife Solutions' employees. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

When is BioLife Solutions' next earnings date?

BioLife Solutions is scheduled to release its next quarterly earnings announcement on Wednesday, March 10th 2021.
View our earnings forecast for BioLife Solutions
.

How were BioLife Solutions' earnings last quarter?

BioLife Solutions, Inc. (NASDAQ:BLFS) issued its earnings results on Thursday, November, 5th. The medical equipment provider reported ($0.02) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.02). The medical equipment provider earned $11.28 million during the quarter, compared to the consensus estimate of $10.71 million. BioLife Solutions had a net margin of 12.67% and a return on equity of 0.53%.
View BioLife Solutions' earnings history
.

What price target have analysts set for BLFS?

10 analysts have issued 1 year price objectives for BioLife Solutions' shares. Their forecasts range from $17.00 to $55.00. On average, they anticipate BioLife Solutions' share price to reach $32.44 in the next twelve months. This suggests that the stock has a possible downside of 24.1%.
View analysts' price targets for BioLife Solutions
or view Wall Street analyst' top-rated stocks.

Who are some of BioLife Solutions' key competitors?

What other stocks do shareholders of BioLife Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioLife Solutions investors own include (CGC), Micron Technology (MU), AbbVie (ABBV), Cara Therapeutics (CARA), Gilead Sciences (GILD), Pfizer (PFE), Rigel Pharmaceuticals (RIGL), Sorrento Therapeutics (SRNE), Twilio (TWLO) and Verastem (VSTM).

Who are BioLife Solutions' key executives?

BioLife Solutions' management team includes the following people:
  • Mr. Michael P. Rice, Pres, CEO & Director (Age 58, Pay $649.25k)
  • Mr. Roderick de Greef, CFO, COO & Sec. (Age 61, Pay $447.78k)
  • Dr. Aby J. Mathew, Chairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer (Age 49, Pay $466.97k)
  • Mr. Todd Berard, Chief Marketing Officer (Age 52)
  • Mr. Marcus Schulz, VP of Global Sales (Age 43)
  • Ms. Karen Foster, Chief Quality Officer (Age 61)

What is BioLife Solutions' stock symbol?

BioLife Solutions trades on the NASDAQ under the ticker symbol "BLFS."

Who are BioLife Solutions' major shareholders?

BioLife Solutions' stock is owned by many different retail and institutional investors. Top institutional shareholders include Gilman Hill Asset Management LLC (0.02%). Company insiders that own BioLife Solutions stock include Aby J Mathew, Andrew G Hinson, Casdin Partners Master Fund, L, Greef Roderick De, James Mathers, Johan Wedell-Wedellsborg, Joseph C Schick, Karen A Foster, Marcus Schulz, Michael Rice, Raymond W Cohen, Thomas Girschweiler, Todd Berard and Walter Villiger.
View institutional ownership trends for BioLife Solutions
.

Which major investors are selling BioLife Solutions stock?

BLFS stock was sold by a variety of institutional investors in the last quarter, including Gilman Hill Asset Management LLC. Company insiders that have sold BioLife Solutions company stock in the last year include Aby J Mathew, Greef Roderick De, James Mathers, Karen A Foster, Marcus Schulz, Michael Rice, Raymond W Cohen, Thomas Girschweiler, Todd Berard, and Walter Villiger.
View insider buying and selling activity for BioLife Solutions
or view top insider-selling stocks.

How do I buy shares of BioLife Solutions?

Shares of BLFS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is BioLife Solutions' stock price today?

One share of BLFS stock can currently be purchased for approximately $42.73.

How big of a company is BioLife Solutions?

BioLife Solutions has a market capitalization of $1.40 billion and generates $27.37 million in revenue each year. The medical equipment provider earns $-1,660,000.00 in net income (profit) each year or $0.08 on an earnings per share basis. BioLife Solutions employs 54 workers across the globe.

What is BioLife Solutions' official website?

The official website for BioLife Solutions is www.biolifesolutions.com.

How can I contact BioLife Solutions?

BioLife Solutions' mailing address is 3303 MONTE VILLA PARKWAY SUITE 310, BOTHELL WA, 98021. The medical equipment provider can be reached via phone at 425-402-1400 or via email at [email protected]

This page was last updated on 1/21/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.